Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy

PURPOSE: Standard imaging studies are limited as outcome measures for patients with metastatic prostate cancer. We tested the hypothesis that serial fluorodeoxyglucose positron emission tomography (FDG-PET) scans can serve as an outcome measure for patients with castrate metastatic prostate cancer t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morris, Michael J., Akhurst, Timothy, Larson, Steven M., Ditullio, Marisa, Chu, Elaina, Siedlecki, Karen, Verbel, David, Heller, Glenn, Kelly, W. Kevin, Slovin, Susan, Schwartz, Lawrence, Scher, Howard I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2005
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2040333/
https://ncbi.nlm.nih.gov/pubmed/15867215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-04-2034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados